In support, a mouse model found that diet-induced obesity increased the severity of atopic dermatitis in an IL-17 dependent manner, and that rosiglitazone suppressed IL-17 and restored the effectiveness of anti-IL-4 and anti-IL-13 therapy (24). This evidence concerns the gene IL17A and atopic eczema.